Universitätsmedizin Mainz

Mainz D-55131

1 studies enrolling now · 16 studies all time

What they study most

Acute Alcoholic Hepatitis, Arrhythmia, Breast Cancer, Carcinoma of the Cervix, Stage IVB, Coronary Artery Disease, Gastric Cancer, Gastroesophageal Junction Cancer, Graves' Ophthalmopathy (GO), HER2-positive Gastric Cancer, Hepatocellular Cancer, Mucopolysaccharidosis II, Multiple Myeloma

Studies at this site

• The PERSEVERE Study — Recruiting now
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) — Running, not enrolling
• Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix — Completed
• A Longitudinal Observational Study of the Natural History and Management of Patients With HCC — Running, not enrolling
• Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma — Stopped early
• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed
• Selinexor Treatment of Refractory Myeloma — Completed
• ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) — Stopped early
• Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. — Completed
• Study Evaluating CERAMENT™|G in Open Diaphyseal Tibial Fractures — Completed
• Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141 — Completed
• FREEZE Cohort Study — Completed
• Phase IIIb Study of APD421 in Combination as PONV Prophylaxis — Completed
• Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD — Stopped early